Patient-reported outcomes (PROs) can be included in clinical trials as primary or secondary
endpoints and are increasingly recognized by regulators, clinicians, and patients as …

In this paper, we provide a domain‐general scoping review of the nudge movement by
reviewing 422 choice architecture interventions in 156 empirical studies. We report the …

Importance Patient-reported outcome (PRO) data from clinical trials can provide valuable
evidence to inform shared decision making, labeling claims, clinical guidelines, and health …

Background It had been more than 5 years since the first case of Middle East Respiratory
Syndrome coronavirus infection (MERS-CoV) was recorded, but no specific treatment has …

Abstract Background The CONSORT (Consolidated Standards of Reporting Trials)
Statement was developed to help biomedical researchers report randomised controlled …

Background Mobile health (mHealth) is emerging as the most convenient way to deliver
rehabilitation services remotely, and collect outcomes in real time, thus contributing to …

Abstract Introduction Autosomal-dominant Alzheimer's disease (ADAD) represents a crucial
population for identifying prevention strategies that might modify disease course for …

Introduction Preliminary evidence supports the beneficial role of physical activity on prostate
cancer outcomes. This phase III randomised controlled trial (RCT) is designed to determine …

Objectives To outline contemporary and novel developments for the presentation and
reporting of syntheses of qualitative, implementation, and process evaluation evidence and …

Congenital diaphragmatic hernia is a rare disease associated with high mortality and
morbidity. Antenatal ultrasound screening identifies more than 70% of cases, providing the …